Prostatitis Center Tucson
  2001 Prostatitis Brainstorming Sessions
  Our Story
  Clinic history
  Frequently Asked Questions (FAQ)
  Dr. Polacheck's Resume
  Research
  Diagnosis
  Empowering patients
  Images
  Location
Prostatitis Center Manila
  Info about Dr. A.E. Feliciano, Jr.
Other Links
  Prostatitis Foundation Website

Prostatitis Center

Tucson, Arizona

Cytology of Expressed Prostatic Secretions

J. Polacheck, E. Vega
Prostatitis Center and Carondelet St. Joseph's Hospital, Tucson, AZ
In order to learn more about the pathophysiology of "chronic" prostatitis, we examined the cytology of expressed prostatic secretions (EPS). In the EPS from most patients with chronic prostatitis, we have observed cohesive aggregates of polymorphonuclear (PMN) leukocytes within a proteinaceous matrix. We call these aggregates prostatic inflammatory aggregates (PIAs). PIAs are frequently associated with corpora amylacea, concretions known to form inside the prostate.
We believe that PIAs may be pathognomonic for prostate inflammation because we have observed, histopathologically, remarkably similar aggregates in prostate tissue obtained surgically. These are normally ignored by surgical pathologists when they are searching for cancer.
We find it remarkable that PIAs can be expressed by massage. We have observed in the surgically obtained prostate tissue that most PIAs are located in the periphery of the prostate gland. Prostatic ducts are tortuous, branching, and very long relative to their narrow diameter. In fact, prostatic ducts appear smaller in diameter than PIAs. Therefore, the ducts must expand and/or the PIAs must deform in order for the PIAs to be expressed.
Based on preliminary studies, we believe the following conclusions are likely:

  1. The inflammatory process is persistently active because the lifespan of PMNs is known to be short, approximately 5 days.

  2. The inflammatory process is likely triggered by a bacteria or a bacteria-like organism because of the predominance of PMNs, not lymphocytes.

  3. PIAs in EPS may prove to be a specific clinical test of disease activity. We have already found it useful in the management of patients.

  4. Because PIAs are found in most prostates with BPH, a relationship could exist between BPH and prostatitis.
Finally, we note the disparity between the clinical disease (chronic symptoms and signs) and its pathology (an acute-inflammatory process). Perhaps this disorder, therefore, should be called "chronic active prostatitis" (CAP).
Return to 1999 NIH abstracts

Contacts

Mail
1701 W. St. Mary's Rd.
Suite 102
Tucson, Arizona 85754
USA
E-mail:
jpolacheck@attglobal.net
Phone :
520-622-4599
Answering Service:
520-570-6011
Fax:
520-903-9972